Hazlett Burt & Watson Inc. elevated its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 21.3% through the second quarter, in keeping with its most up-to-date 13F submitting with the Securities and Trade Fee. The fund owned 17,742 shares of the corporate’s inventory after buying a further 3,116 shares through the quarter. Johnson & Johnson includes 1.3% of Hazlett Burt & Watson Inc.’s portfolio, making the inventory its eleventh largest holding. Hazlett Burt & Watson Inc.’s holdings in Johnson & Johnson have been price $2,590,000 as of its most up-to-date SEC submitting.
A number of different massive traders additionally lately modified their holdings of the inventory. Norges Financial institution purchased a brand new place in shares of Johnson & Johnson through the fourth quarter price roughly $4,071,642,000. Wellington Administration Group LLP grew its holdings in Johnson & Johnson by 16.4% within the 4th quarter. Wellington Administration Group LLP now owns 24,019,725 shares of the corporate’s inventory valued at $3,764,852,000 after shopping for a further 3,391,657 shares within the final quarter. Value T Rowe Associates Inc. MD elevated its place in Johnson & Johnson by 16.8% through the 1st quarter. Value T Rowe Associates Inc. MD now owns 21,834,359 shares of the corporate’s inventory price $3,453,978,000 after shopping for a further 3,139,499 shares through the interval. Ninety One UK Ltd lifted its holdings in shares of Johnson & Johnson by 59.0% through the second quarter. Ninety One UK Ltd now owns 6,708,943 shares of the corporate’s inventory price $980,579,000 after shopping for a further 2,489,925 shares within the final quarter. Lastly, Swedbank AB purchased a brand new stake in shares of Johnson & Johnson within the first quarter valued at about $331,178,000. 69.55% of the inventory is owned by institutional traders.
Wall Avenue Analyst Weigh In
A number of analysts have weighed in on the inventory. Sanford C. Bernstein lifted their value goal on shares of Johnson & Johnson from $161.00 to $171.00 in a analysis observe on Thursday, July 18th. TD Cowen reduce their value goal on Johnson & Johnson from $195.00 to $185.00 and set a “purchase” score for the corporate in a analysis observe on Thursday, July 18th. Morgan Stanley raised their value goal on Johnson & Johnson from $167.00 to $169.00 and gave the inventory an “equal weight” score in a analysis observe on Thursday, July 18th. StockNews.com lowered Johnson & Johnson from a “strong-buy” score to a “purchase” score in a report on Friday, September sixth. Lastly, Cantor Fitzgerald reaffirmed an “chubby” score and issued a $215.00 value goal on shares of Johnson & Johnson in a analysis observe on Monday. Seven equities analysis analysts have rated the inventory with a maintain score and 7 have given a purchase score to the inventory. In keeping with knowledge from MarketBeat, Johnson & Johnson presently has a median score of “Average Purchase” and a consensus goal value of $173.21.
Learn Our Newest Analysis Report on JNJ
Johnson & Johnson Inventory Efficiency
NYSE JNJ opened at $164.64 on Friday. Johnson & Johnson has a fifty-two week low of $143.13 and a fifty-two week excessive of $168.85. The inventory has a market cap of $396.24 billion, a PE ratio of 10.26, a PEG ratio of two.71 and a beta of 0.53. The corporate has a debt-to-equity ratio of 0.44, a fast ratio of 0.85 and a present ratio of 1.07. The agency’s fifty day transferring common value is $159.17 and its two-hundred day transferring common value is $154.00.
Johnson & Johnson (NYSE:JNJ – Get Free Report) final issued its earnings outcomes on Wednesday, July seventeenth. The corporate reported $2.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.71 by $0.11. Johnson & Johnson had a return on fairness of 36.60% and a web margin of 46.34%. The enterprise had income of $22.45 billion through the quarter, in comparison with analysts’ expectations of $22.33 billion. Throughout the identical quarter within the prior yr, the agency earned $2.80 EPS. The enterprise’s income for the quarter was up 4.3% in comparison with the identical quarter final yr. On common, equities analysts anticipate that Johnson & Johnson will publish 10.02 EPS for the present fiscal yr.
Johnson & Johnson Dividend Announcement
The agency additionally lately declared a quarterly dividend, which was paid on Tuesday, September tenth. Shareholders of report on Tuesday, August twenty seventh got a $1.24 dividend. This represents a $4.96 annualized dividend and a yield of three.01%. The ex-dividend date was Tuesday, August twenty seventh. Johnson & Johnson’s dividend payout ratio (DPR) is at present 30.92%.
Insider Exercise
In associated information, VP Robert J. Decker bought 5,635 shares of the enterprise’s inventory in a transaction on Friday, August thirtieth. The shares have been bought at a median value of $165.06, for a complete worth of $930,113.10. Following the sale, the vp now owns 18,973 shares of the corporate’s inventory, valued at $3,131,683.38. The sale was disclosed in a authorized submitting with the SEC, which is accessible by the SEC web site. Insiders personal 0.16% of the corporate’s inventory.
Johnson & Johnson Firm Profile
Johnson & Johnson, along with its subsidiaries, researches, develops, manufactures, and sells varied merchandise within the healthcare area worldwide. The corporate’s Progressive Drugs phase presents merchandise for varied therapeutic areas, comparable to immunology, together with rheumatoid arthritis, psoriatic arthritis, inflammatory bowel illness, and psoriasis; infectious ailments comprising HIV/AIDS; neuroscience, consisting of temper problems, neurodegenerative problems, and schizophrenia; oncology, comparable to prostate most cancers, hematologic malignancies, lung most cancers, and bladder most cancers; cardiovascular and metabolism, together with thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension by retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
Really useful Tales
Need to see what different hedge funds are holding JNJ? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).
Obtain Information & Scores for Johnson & Johnson Every day – Enter your e mail handle under to obtain a concise day by day abstract of the most recent information and analysts’ rankings for Johnson & Johnson and associated corporations with MarketBeat.com’s FREE day by day e mail publication.
